CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Planned sale Chief Financial Officer sold 127,544 shares at $1.66 ($211,366)
- 4 Planned sale Chief Medical Officer sold 101,740 shares at $1.66 ($168,604)
- 4/A Planned sale Chief Medical Officer sold 125,894 shares at an average $1.99 ($250,932)
- 4 Planned sale Chief Financial Officer sold 83,021 shares at an average $2.04 ($169,646)
- 4 Planned sale Chief Medical Officer sold 125,894 shares at an average $1.99 ($250,938)
- 4 Planned sale Chief Legal Officer sold 30,845 shares at $2.01 ($61,860)
- 4 Planned sale Chief Operating Officer sold 34,094 shares at $2.01 ($68,376)
- 4 Planned sale President and CEO sold 78,187 shares at $2.01 ($156,804)
- 4 Grant or award Chief Medical Officer acquired 264,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 300,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,200,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 420,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 300,000 shares (grant or award)
- 4 Planned sale Chief Legal Officer sold 55,000 shares at $1.70 ($93,500)
- 4 Open-market buy Director bought 25,000 shares at $1.25 ($31,250)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
Page 2 of 36 · 701 filings